|
|
Other links at Articles > Cardiology |
| 3. |
FDA Safety Changes: Gleevec, Keppra, Neupogen
|
|
|
The FDA has approved revisions to the safety labeling for imatinib mesylate tablets (Gleevec), levetiracetam injection (Keppra), and filgrastim injection (Neupogen). Medscape Medical News
|
| 4. |
HF up in Recent Decades as MI Deaths Fall
|
|
|
A decline in deaths from MI in recent decades appears to have been accompanied by an increase in the incidence of heart failure, according to a new analysis from the Framingham Heart Study. The likely explanation is that sicker patients, who would have died from MI in earlier years, are now surviving but going on to develop HF, say the researchers. Heartwire
|
|
|
